Dengue fever

What Is Dengue Fever?

Dengue fever is a mosquito borne viral illness caused by the dengue virus, a member of the flavivirus family transmitted primarily through the bite of infected Aedes mosquitoes.¹

Four distinct viral serotypes cause dengue fever, and infection with one serotype does not protect against the others, meaning a person can potentially be infected with dengue more than once over the course of their life, with subsequent infections sometimes carrying greater risk of severe disease.¹

Most people infected with dengue virus experience no symptoms at all, though those who do become ill typically develop symptoms within four to ten days of infection, generally lasting between two and seven days.²

Most people who get dengue do not have symptoms, and if symptoms occur, they usually begin four to ten days after infection and last for two to seven days.
Centers for Disease Control and Prevention

Symptoms

When symptomatic, dengue fever most commonly produces high fever, headache, body aches, nausea, and a distinctive rash.²

About one in twenty people who become symptomatically ill with dengue will go on to develop severe dengue, a considerably more dangerous form of the disease that can result in shock, internal bleeding, and death if not promptly recognized and treated.³

Warning signs signaling possible progression toward severe dengue typically emerge within twenty four to forty eight hours after fever subsides, and include worsening abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, and lethargy, all of which warrant urgent medical evaluation.³

Causes

Dengue virus is transmitted to humans through the bite of infected female Aedes aegypti mosquitoes, which are distinctive daytime feeders most active during early morning and evening hours before dusk.²

These mosquitoes typically breed in standing water found in everyday containers, including buckets, flowerpots, animal water dishes, and discarded items capable of holding even small amounts of water.²

Because Aedes mosquitoes also transmit several other significant viral diseases, including Zika, chikungunya, and yellow fever, comprehensive mosquito control efforts targeting this species carry benefits extending well beyond dengue prevention alone.⁴

Risk Factors

Living in or traveling to regions with established Aedes mosquito populations and ongoing dengue transmission represents the primary risk factor for infection, with tropical and subtropical regions carrying the highest overall risk.

A prior dengue infection with a different viral serotype can, somewhat counterintuitively, increase the risk of developing severe dengue during a subsequent infection, reflecting the complex immunological interactions between the four distinct dengue serotypes.¹

Children represent a population of particular concern regarding certain dengue vaccines, since dengue naive children under nine years of age face elevated risk of severe dengue when vaccinated with one of the currently available vaccine formulations.⁵

Complications

Severe dengue represents the most serious potential complication of infection, capable of progressing to shock, significant internal bleeding, and death without prompt, appropriate medical management.³

Because warning signs for severe dengue often emerge only after the initial fever has already subsided, patients and caregivers may mistakenly believe recovery is underway precisely when close monitoring matters most.³

Responsive fluid management represents a central component of preventing progression from uncomplicated dengue to shock or other severe manifestations, underscoring the importance of appropriate clinical monitoring throughout the illness course.⁶

Treatment

No specific antiviral treatment currently exists for dengue fever, and management remains supportive, centered on careful fluid management and appropriate symptom control.⁶

Acetaminophen represents the preferred medication for fever and pain control during dengue infection, since other common pain relievers can increase bleeding risk in a disease already associated with potential bleeding complications.⁶

Close monitoring for warning signs of severe dengue, combined with appropriately responsive fluid management, remains the cornerstone of preventing progression to the most dangerous complications of the disease.⁶

Prevention

Two live attenuated dengue vaccines are currently available in various dengue endemic countries, though they differ meaningfully in both effectiveness and safety profile depending on prior dengue exposure and age.⁵

The newer of these two vaccines has demonstrated higher overall effectiveness after twelve months compared to the older vaccine, though it does not appear to provide protection against one specific viral serotype among people without prior dengue exposure.⁵

Comprehensive mosquito control, including elimination of standing water breeding sites and emerging approaches such as introducing Wolbachia bacteria into mosquito populations to reduce their ability to transmit the virus, remains an essential complement to vaccination in effective dengue prevention strategy.⁴

Why Visual Communication Matters for Dengue Fever

Explaining how a single mosquito bite can transmit one of four distinct viral serotypes, each with different implications for future infection severity, requires visuals that make this layered immunological complexity understandable to patients and travelers.

Pharmaceutical companies, public health organizations, and travel medicine practices rely on clear illustration and animation to explain dengue fever and support effective prevention efforts.

• Illustrating Aedes mosquito biology and breeding habits
• Animating how prior infection with one serotype affects future infection severity
• Explaining warning signs that signal progression toward severe dengue
• Visualizing the mechanism of action of currently available dengue vaccines
• Supporting public health education on mosquito control strategies
• Creating training materials for infectious disease and travel medicine clinicians

How Biotic Artlab Supports Dengue Fever Communication

We work with pharmaceutical companies, public health organizations, and travel medicine practices to create accurate, engaging visuals that make dengue fever and its prevention easier to understand.

• Custom 3D animations of dengue virus transmission and mosquito biology
• Detailed illustrations of severe dengue warning signs and disease progression
• Mechanism of action animations for currently available dengue vaccines
• Patient facing materials for travelers to dengue endemic regions
• Clinical training content for infectious disease and travel medicine teams
• Conference presentations and public health materials for vector control programs

Frequently Asked Questions

Can you get dengue fever more than once?

Yes, there are four distinct dengue virus serotypes, and infection with one does not protect against the others, with subsequent infections sometimes carrying higher risk of severe disease.¹

What are the warning signs of severe dengue?

Worsening abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, and lethargy signal possible progression to severe dengue and require urgent evaluation.³

Is there a specific treatment for dengue fever?

No, treatment remains supportive, focused on fluid management and acetaminophen for symptom control, since no specific antiviral treatment currently exists.⁶

Are dengue vaccines available?

Yes, two live attenuated vaccines are available in dengue endemic countries, though their effectiveness and safety profiles differ based on age and prior dengue exposure.⁵

How can dengue be prevented besides vaccination?

Eliminating mosquito breeding sites, such as standing water in containers, and broader vector control programs remain essential prevention strategies.⁴

When are Aedes mosquitoes most active?

Aedes aegypti mosquitoes are daytime feeders, with peak biting activity occurring in early morning and evening hours before dusk.²

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or public health communication related to dengue fever, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Dengue Fever.
2. Centers for Disease Control and Prevention. Symptoms of Dengue and Testing.
3. Centers for Disease Control and Prevention. Severe Dengue, Know the Warning Signs.
4. National Center for Biotechnology Information. Managing and Controlling Diseases Transmitted by Aedes Mosquitoes, a Review on Best Practices.
5. National Center for Biotechnology Information. Current Status of the Development of Dengue Vaccines.
6. National Center for Biotechnology Information. Dengue, Moving From Current Standard of Care to State of the Art Treatment.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.